SCM
TMO icon

Stellar Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Stellar Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$4.81M Buy
13,273
+98
+0.7% +$32.8K 3.27% 7
2020
Q1 		$3.74M Sell
13,175
-1,125
-8% -$355K 3.07% 8
2019
Q4 		$4.65M Sell
14,300
-287
-2% -$87K 2.72% 9
2019
Q3 		$4.25M Sell
14,587
-569
-4% -$163K 2.74% 9
2019
Q2 		$4.15M Hold
15,156
– – 2.71% 10
2019
Q1 		$4.15M Sell
15,156
-100
-0.7% -$24.9K 2.71% 10
2018
Q4 		$3.42M Buy
15,256
+105
+0.7% +$24.6K 2.67% 11
2018
Q3 		$3.7M Sell
15,151
-260
-2% -$59.8K 2.37% 12
2018
Q2 		$3.19M Sell
15,411
-75
-0.5% -$15.9K 2.09% 15
2018
Q1 		$3.2M Sell
15,486
-188
-1% -$39.5K 2.07% 16
2017
Q4 		$2.98M Sell
15,674
-120
-0.8% -$23K 1.98% 19
2017
Q3 		$2.99M Buy
15,794
+200
+1% +$36.2K 2.1% 17
2017
Q2 		$2.72M Sell
15,594
-25
-0.2% -$4.2K 1.98% 22
2017
Q1 		$2.4M Sell
15,619
-395
-2% -$60.4K 1.83% 24
2016
Q4 		$2.26M Buy
+16,014
New +$2.36M 1.86% 23
2016
Q2 		$2.27M Sell
15,339
-100
-0.6% -$14.8K 2.47% 17
2016
Q1 		$2.19M Buy
15,439
+410
+3% +$54.9K 2.42% 17
2015
Q4 		$2.13M Sell
15,029
-900
-6% -$120K 2.57% 14
2015
Q3 		$1.95M Sell
15,929
-125
-0.8% -$16.3K 2.52% 18
2015
Q2 		$2.08M Sell
16,054
-2,286
-12% -$298K 2.28% 20
2015
Q1 		$2.46M Sell
18,340
-70
-0.4% -$9.02K 2.39% 13
2014
Q4 		$2.31M Sell
18,410
-280
-1% -$34K 2.48% 13
2014
Q3 		$2.27M Sell
18,690
-245
-1% -$29.8K 2.5% 13
2014
Q2 		$2.23M Buy
18,935
+975
+5% +$115K 2.46% 14
2014
Q1 		$2.16M Hold
17,960
– – 2.42% 15
2013
Q4 		$2M Buy
+17,960
New +$1.79M 2.14% 18

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stellar Capital Management's TMO Position: Q2 2020 in Review

Stellar Capital Management increased its Thermo Fisher Scientific (TMO) stake by 0.74% in Q2 2020, buying an estimated $32.8K and bringing the position to 13,273 shares worth $4.81M. The position accounts for 3.27% of the portfolio, ranked #7.

Stellar Capital Management first reported a position in TMO in Q4 2013 and has held it in 26 quarters since. 1,748 funds tracked by Wall St. Rank hold TMO as of Q2 2020.

  • Stellar Capital Management held 13,273 shares of Thermo Fisher Scientific worth $4.81M as of Q2 2020.
  • Stellar Capital Management bought 98 Thermo Fisher Scientific shares in Q2 2020, an estimated $32.8K.
  • Thermo Fisher Scientific made up 3.27% of Stellar Capital Management's portfolio in Q2 2020, its #7 holding.
  • Stellar Capital Management first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 26 quarters since.
  • 1,748 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2020.

Based on Stellar Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.